NN-4101

N/A

Report date: 2025/03/13 16:56:01

First In Class

Base Information

Drug NameNN-4101

Drug Alias NameNN4101NN-4101

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionVascular endothelial growth factor modulatorsStem cell growth factor receptor modulators

TargetsVascular endothelial growth factorStem cell growth factor receptor

Therapy Area/IndicationsRetinal Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNovelty Nobility Inc

China Registration ClassN/A

Develop Information

Active CompaniesNovelty Nobility Inc

Inactive CompaniesN/A

Active IndicationsRetinal Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A